McNeill Lori
SEC insider (Form 3/4/5 filer). CIK 0001949324. Director at Sonnet BioTherapeutics Holdings, Inc. (SONN). 3 reported Form 4/5 transactions since Sep 2024; latest on Dec 2, 2025. Located in PRINCETON,, NJ.
Companies McNeill Lori has filed insider reports for
- Sonnet BioTherapeutics Holdings, Inc. (SONN): Director
McNeill Lori
CIK: 0001949324
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)1 (33.3%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SONN
Sonnet BioTherapeutics Holdings, Inc.
Director